
Jay Bregman, founder and CEO of Andel, discusses the current GLP-1 landscape and how a new Medicare initiative is designed to improve access to this increasingly popular medication class.

Jay Bregman, founder and CEO of Andel, discusses the current GLP-1 landscape and how a new Medicare initiative is designed to improve access to this increasingly popular medication class.

In-home pharmacist visits uncover medication risks, improve adherence and deprescribing, and help older adults stay safer at home.

In part 2 of our interview, Esmé Grewal, JD, discusses the key opportunities LTC pharmacies possess in assisting the aging population in medication management.

Lisa Lavin, founder, chairman, and CEO of Ōmcare, discusses the Rural Health Innovation Initiative and how collaboration is bringing pharmacy care to rural Minnesota and beyond.

Sponsored Content
In a shifting environment, pharmacy success is no longer just about scale but about earning patient trust through consistency and effectively managing affordability.

Tarah Davis, PharmD, MBA, AFMC, discusses the superpower of personalized patient roadmaps and how identifying drug-induced nutrient depletions is the key to resolving digestive dysfunction.

Sponsored Content
Pharmacy reimbursement stability is built on transparency, financial visibility, and an understanding of upcoming industry shifts.

Sponsored Content
Community pharmacies have become one of the most accessible points of care for patients, especially in rural and underserved communities.

Harini Bupathi, Esq, discusses the basis of PBM audits, why they exist, and how pharmacies can anticipate them.

AI reshapes everyday tasks in the community pharmacy from refill automation to documentation.

Julia Vu, PharmD, joins to discuss industry-impacting NCPDP standards and how they are introducing new processes for medication delivery.

With insights from executives working around the clock to advance the pharmacy profession, our experts predicted what the landscape will look like following the Consolidated Appropriations Act of 2026.

Pharmacist and diabetes expert Sandra Leal, PharmD, MPH, joins to discuss the importance of engaging pharmacists within primary care diabetes teams.

Pharmacies can build clinical workflows, bill like providers, and get paid for MTM and test-and-treat services patients value.

An open line of communication between care teams is key to improving patient outcomes.

Lisa Miller, PharmD, MSCP, discusses fragmentation in US menopause care and the role pharmacists can play in improving collaboration.

Controlling symptoms of allergy and asthma helps patients improve quality of life.

Declining Black-owned pharmacies reshape community care, and pharmacists can advance health equity today.

Jeffery Goad, PharmD, MPH, president of the National Foundation for Infectious Diseases, provided his expert perspectives on the ongoing hantavirus outbreak.

From PBM reform designed to benefit pharmacies to closures impacting the greater public health sector, Tom DePietro, PharmD, discusses current developments in community pharmacy.

Black pharmacists help to power civil rights, voter drives, and community care, linking history to today’s fight for health equity.

Black pharmacists help to fuel civil rights—through drugstores, voter drives, and health equity—offering lessons for today’s care gaps.

An exploration of key takeaways from the first 4 episodes of Scripted for Her, featuring host Natalie DiPietro Mager, PharmD, PhD, and experts from a variety of clinical backgrounds in women’s health.

Mapping data reveals where pharmacy access collapses and how policymakers can fight medication deserts.

Pharmacists expand into vaccines and telehealth, but state laws and reimbursement gaps persist.

Beyond medications, lifestyle modifications can also help patients curb allergy symptoms.

Susan Cornell, PharmD, CDCES, FAPhA, FADCES, and Staci-Marie Norman, PharmD, CDCES, FAPhA, discuss current trends regarding CGM use and access behind the pharmacy counter.

Medicare’s new GLP‑1 bridge program launches soon, easing access without shortages, and pharamcists are at the focal point of these transitions.

CMS pilots BALANCE and GLP-1 Bridge models to widen Medicare/Medicaid obesity drug coverage, spotlighting pharmacists’ role in access and safe therapy.

A PQA program shows how value-based pharmacy contracts, shared metrics, and better data boost immunizations and patient outcomes beyond dispensing.